References

Angen, O., M. Andreasen, E.O. Nielsen, A. Stockmarr and P. Baekbo, 2008. Effect of tulathromycin on the carrier status of Actinobacillus pleuropneumoniae serotype 2 in the tonsils of pigs. Vet. Rec., 163: 445-447.
CrossRef  |  

Benchaoui, H.A., M. Nowakowski., J. Sherington., T.G. Rowan and S.J. Sunderland, 2004. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J. Vet. Pharmacol. Ther., 27: 203-210.
CrossRef  |  

Burrows, P.E., L.N. Benson, C.A. Moes and R.M. Freedom, 1989. Pulmonary artery tears following balloon valvotomy for pulmonary stenosis. Cardiovasc. Intervent. Radiol., 12: 38-42.
CrossRef  |  PubMed  |  

Godinho, K.S., 2008. Susceptibility testing of tulathromycin: Interpretative breakpoints and susceptibility of field isolates. Vet. Microbiol., 129: 426-432.
CrossRef  |  

Hellman, K., C.J. Keane and K.S. Godinho, 2008. Therapeutic and methaphylactic efficacy of tulathromycin (DRAXXIN (R)) in porcine respiratory disease in Europe associated with Haemophilus parasuis. Tieraerztliche Umschau, 63: 615-620.

Icen, H., S. Sekin, S. Yesilmen, N. Isik and A. Simsek, 2009. Viral and bacterial pathogen isolated and identified from pneumonic calves in region of diyarbakir and its treatment with tulathromycin. J. Anim. Vet. 8: 1545-1550.
Direct Link  |  

Lam, F.C., C.T. Hung and D.G. Perrier, 1985. Estimation of variance for harmonic mean half-lives. J. Pharm. Sci., 74: 229-231.
CrossRef  |  

McKelvie, J., J.H. Morgan, I.A. Nanjiani, J. Sherington, T.G. Rowan and S.J. Sunderland, 2005. Evaluation of tulathromycin for the treatment of pneumonia following experimental infection of swine with mycoplasma hyopneumoniae. Vet. Ther., 6: 197-202.
PubMed  |  

Nicolet, J., 1992. Actinobacillus pleuropneumoniae. In: Diseases of Pigs, Leman, A.D., B.E. Straw, W.L. Mengeling, S. D'Allaire and D.J. Taylor (Eds.). Wolfe Press, London, pp: 401-407.

Nowakowski, M.A., P.B. Inskeep, J.E. Risk, T.L. Skogerboe and H.A. Benchaoui et al., 2004. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet. Ther., 5: 60-74.
PubMed  |  Direct Link  |  

Ragbetli, C., I. Yoruk, M. Cay and P. Tanritanir, 2009. The effect of tulathromycin treatment on antioxidant vitamins in montofon calves with pneumonia. J. Anim. Vet. Adv., 8: 2345-2349.
Direct Link  |  

Skogerboe, T.L., K.A. Rooney, R.G. Nutsch, D.J. Weigel, K. Gajewski and W.R. Kilgore, 2005. Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. Vet. Ther., 6: 180-196.
PubMed  |  

Taylor, D., 1999. Actinobacillus Pleuropneumoniae. In: Diseases of Swine, Straw, B., S. D'Allaire, W. Mengeling and D. Taylor (Eds.). 8th Edn., John Wiley and Sons, USA., pp: 343-354.

Washburn, K.E., W. Bissett, V. Fajt, F. Clubb, G.T. Fosgate et al., 2007. The safety of tulathromycin administration in goats. J. Vet. Pharmacol. Therapeut., 30: 267-270.
CrossRef  |  

Young, G., G.W. Smith, T.L. Leavens, S.E. Wetzlich and R.E. Baynes et al., 2011. Pharmacokinetics of tulathromycin following subcutaneous administration in meat goats. Res. Vet. Sci., 90: 477-479.
CrossRef  |  PubMed  |